Insider Trading Activity PRA Health Sciences, Inc. (NASDAQ:PRAH) – CEO Sold 400,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For PRA Health Sciences, Inc. (NASDAQ:PRAH)

Colin Shannon , CEO of PRA Health Sciences, Inc. (NASDAQ:PRAH) reportedly Sold 400,000 shares of the company’s stock at an average price of 74.85 for a total transaction amount of $29,940,000.00 SEC Form

Insider Trading History For PRA Health Sciences, Inc. (NASDAQ:PRAH)

  • On 3/8/2016 Pra Investors L.P. Kkr, Major Shareholder, sold 4,829,981 with an average share price of $42.26 per share and the total transaction amounting to $204,114,997.06.View SEC Filing
  • On 3/8/2016 Linda Baddour, CFO, sold 93,000 with an average share price of $42.26 per share and the total transaction amounting to $3,930,180.00.View SEC Filing
  • On 3/8/2016 Colin Shannon, CEO, sold 77,019 with an average share price of $42.26 per share and the total transaction amounting to $3,254,822.94.View SEC Filing
  • On 5/6/2016 Pra Investors L.P. Kkr, Major Shareholder, sold 4,907,692 with an average share price of $46.70 per share and the total transaction amounting to $229,189,216.40.View SEC Filing
  • On 5/6/2016 Linda Baddour, CFO, sold 92,308 with an average share price of $46.70 per share and the total transaction amounting to $4,310,783.60.View SEC Filing
  • On 8/12/2016 David W. Dockhorn, VP, sold 107,257 with an average share price of $49.00 per share and the total transaction amounting to $5,255,593.00.View SEC Filing
  • On 8/15/2016 Linda Baddour, VP, sold 69,380 with an average share price of $52.00 per share and the total transaction amounting to $3,607,760.00.View SEC Filing

    • Analyst Ratings For PRA Health Sciences, Inc. (NASDAQ:PRAH)
    These are 1 Hold Rating, 7 Buy Ratings .
    The current consensus rating for PRA Health Sciences, Inc. (NASDAQ:PRAH) is Buy (Score: 2.88) with a consensus target price of $84.00 , a potential (11.76% upside)

    Analyst Ratings History For PRA Health Sciences, Inc. (NASDAQ:PRAH)

    • On 8/21/2015 William Blair Reiterated Rating Outperform
    • On 6/20/2016 First Analysis Initiated Coverage of rating Equal to Equal Weight with a price target of $47.00
    • On 11/4/2016 KeyCorp Reiterated Rating Buy
    • On 2/27/2017 Avondale Partners Upgraded rating Underperform to Market Perform with a price target of $63.00
    • On 6/26/2017 Bank of America Corporation Initiated Coverage of rating Buy with a price target of $89.00
    • On 8/8/2017 Robert W. Baird Boost Price Target of rating Outperform with a price target of $82.00 to $83.00
    • On 8/8/2017 Credit Suisse Group Boost Price Target of rating Outperform to Outperform with a price target of $80.00 to $84.00

    Recent Trading Activity for PRA Health Sciences, Inc. (NASDAQ:PRAH)
    Shares of PRA Health Sciences, Inc. closed the previous trading session at 75.16 down -0.54 -0.71% with 1,894,425 shares trading hands.